EVAOLDHot Line 11Interventional Cardiology
Evaluation of Reperfusion Strategies in Elderly Patients
Evaluation of reperfusion strategies in elderly patients
Presenting authorGilles Barone-RochetteInterventional / Structural Cardiology · University Hospital of Grenoble, FranceGilles Barone-Rochette is a Professor of Cardiology (PU-PH) and interventional cardiologist at Centre Hospitalier Universitaire de Grenoble Alpes and Université Grenoble Alpes. He specializes in coronary artery disease using invasive and non-invasive multimodal imaging and is responsible for the CHU competence centre for cardiomyopathies. He heads the cardiology research unit affiliated with INSERM UMR 1039.
Overview
Pending trial data leave optimal reperfusion undefined in elderly patients; leaves open practice recommendations until full results emerge.
Key result
Reperfusion strategies in elderly patients are being evaluated in a late-breaking trial, but specific clinical results are currently pending.
Discussion
Expert reaction lands here the moment EVAOLD reports.
Key Points
- Evaluation of reperfusion strategies aims to determine optimal treatment pathways in elderly patients presenting with cardiovascular conditions.
- Clinical trial presentation at ESC Congress 2026 reports ongoing evaluation where final efficacy and safety results are currently pending.
- Trial evaluation assesses diverse reperfusion strategies across elderly cohorts to clarify outcomes in higher-risk demographic groups.
Main Result
Absolute Event Rate: 0% vs 0%